Morgan Stanley Mirum Pharmaceuticals, Inc. Transaction History

Morgan Stanley

$1.39 Trillion
Q4 2024

A detailed history of Morgan Stanley transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Morgan Stanley holds 758,380 shares of MIRM stock, worth $33.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

758,380

Previous 625,916 21.16%

Holding current value

$33.6 Million

Previous $24.4 Million 28.47%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$37.85 - $46.65 $5.01 Million - $6.18 Million	132,464 Added 21.16%	758,380 $31.4 Million
Q3 2024 Nov 14, 2024	BUY	$33.68 - $44.74 $2.86 Million - $3.8 Million	84,894 Added 15.69%	625,916 $24.4 Million
Q2 2024 Oct 17, 2024	BUY	$23.57 - $34.85 $4.39 Million - $6.5 Million	186,434 Added 52.58%	541,022 $18.5 Million
Q2 2024 Aug 14, 2024	BUY	$23.57 - $34.85 $4.39 Million - $6.5 Million	186,434 Added 52.58%	541,022 $18.5 Million
Q1 2024 Oct 17, 2024	SELL	$24.92 - $30.02 $4.65 Million - $5.6 Million	-186,434 Reduced 34.46%	354,588 $8.91 Million
Q1 2024 Aug 16, 2024	BUY	$24.92 - $30.02 $2.74 Million - $3.3 Million	109,897 Added 44.91%	354,588 $8.91 Million
Q1 2024 May 15, 2024	BUY	$24.92 - $30.02 $2.74 Million - $3.3 Million	109,897 Added 44.91%	354,588 $8.91 Million
Q4 2023 Aug 16, 2024	SELL	$27.14 - $34.93 $8.04 Million - $10.4 Million	-296,331 Reduced 54.77%	244,691 $7.22 Million
Q4 2023 Feb 13, 2024	BUY	$27.14 - $34.93 $2.65 Million - $3.42 Million	97,775 Added 66.55%	244,691 $7.22 Million
Q3 2023 Nov 15, 2023	BUY	$24.63 - $32.85 $1.05 Million - $1.39 Million	42,437 Added 40.62%	146,916 $4.64 Million
Q2 2023 Aug 14, 2023	BUY	$23.51 - $30.09 $1.42 Million - $1.81 Million	60,285 Added 136.41%	104,479 $2.7 Million
Q1 2023 May 15, 2023	SELL	$19.19 - $24.1 $645,417 - $810,555	-33,633 Reduced 43.22%	44,194 $1.06 Million
Q4 2022 Feb 14, 2023	SELL	$17.59 - $23.83 $296,321 - $401,440	-16,846 Reduced 17.79%	77,827 $1.52 Million
Q3 2022 Nov 14, 2022	SELL	$19.98 - $29.44 $819,020 - $1.21 Million	-40,992 Reduced 30.22%	94,673 $1.99 Million
Q2 2022 Oct 27, 2022	BUY	$18.42 - $27.5 $1.92 Million - $2.87 Million	104,363 Added 333.41%	135,665 $2.64 Million
Q2 2022 Aug 15, 2022	BUY	$18.42 - $27.5 $1.92 Million - $2.87 Million	104,363 Added 333.41%	135,665 $2.64 Million
Q1 2022 Oct 27, 2022	SELL	$15.5 - $23.93 $1.62 Million - $2.5 Million	-104,363 Reduced 76.93%	31,302 $690,000
Q1 2022 May 13, 2022	BUY	$15.5 - $23.93 $21,142 - $32,640	1,364 Added 4.56%	31,302 $690,000
Q4 2021 Feb 14, 2022	BUY	$13.05 - $19.35 $246,814 - $365,966	18,913 Added 171.55%	29,938 $477,000
Q3 2021 Nov 15, 2021	BUY	$13.95 - $20.18 $153,798 - $222,484	11,025 New	11,025 $220,000

Others Institutions Holding MIRM

# of Institutions

211

Shares Held

53.8M

Call Options Held

2.6K

Put Options Held

99.7K

View Full List

About Mirum Pharmaceuticals, Inc.

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.63B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

More about MIRM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account